Claraphi Advisory Network’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Claraphi Advisory Network's REGN Position: Q2 2022 in Review
Claraphi Advisory Network sold out of Regeneron Pharmaceuticals (REGN) in Q2 2022, closing a stake of 852 shares — an estimated $595K sold.
Claraphi Advisory Network first reported a position in REGN in Q1 2020 and held it in 6 quarters. The position peaked at $1.34M in Q2 2021. 1,064 funds tracked by Wall St. Rank hold REGN as of Q2 2022.
- Claraphi Advisory Network reported no remaining Regeneron Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
- Claraphi Advisory Network sold 852 Regeneron Pharmaceuticals shares in Q2 2022, an estimated $595K.
- Claraphi Advisory Network first reported a position in Regeneron Pharmaceuticals in Q1 2020 and held it in 6 quarters.
- Claraphi Advisory Network's Regeneron Pharmaceuticals position peaked at $1.34M in Q2 2021.
- 1,064 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2022.
Based on Claraphi Advisory Network's 13F filing for Q2 2022, filed 19 Jul 2022.